Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Jun Tan, PhD
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces amyloidosis in Alzheimer’s transgenic mice
A GuideStar-Rated Charity
© Copyright 2025. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).